trending Market Intelligence /marketintelligence/en/news-insights/trending/JAWMabxFVJ9qQub3kHNOmA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Aetna still mulling next move on court-blocked Humana deal

Infrastructure Issues: Tools to Dig Deep on Potential Risks

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools

2018 US Property Casualty Insurance Market Report

Fintech

Fintech Funding Flows To Insurtech In February


Aetna still mulling next move on court-blocked Humana deal

Aetna Inc. is still reviewing its options in response to a trial court's ruling that blocked the company's planned acquisition of Humana Inc., according to chairman and CEO Mark Bertolini.

Speaking during an earnings call, Bertolini said the company could appeal the court's ruling or scuttle the deal. The company's merger agreement will expire Feb. 15, and therefore the company is "in no rush" and "will take all of that time" to reach a decision on whether or not to appeal, the executive said.

A federal judge, in a Jan. 23 opinion, ruled that the deal would significantly diminish competition in the Medicare Advantage market, siding with the U.S. Department of Justice, which brought the lawsuit to stop the merger. The court's disapproval to the merger came despite a proposal by Aetna and Humana to divest their Medicare Advantage plans to Molina Healthcare Inc. — a deal predicated on the Aetna-Humana merger occurring.

"I think the one thing that we could say about our [divestiture package] and some of the criticisms that are in the opinion by the judge is that the DOJ is looking for sustainable competition," Bertolini said with regard to the department's view of the company's proposal to sell its Medicare Advantage assets.

While evaluating the divestiture proposal, the DOJ was concerned whether the potential buyer had "a management team, and infrastructure and ability to remain in the markets, particularly in a retail product," Bertolini said. But he declined to comment whether there is any "flexibility in an appeal process" if Aetna finds a different suitor for its Medicare Advantage assets, saying it is still too early "to have that kind of conversation."